Vaccine star Kate Bingham’s biotech fund gets $50m in taxpayer cash | Business | The Times

Vaccine star Kate Bingham’s biotech fund gets $50m in taxpayer cash | Business | The Times

A life sciences fund launched by the investment firm of Dame Kate Bingham, the venture capitalist lauded for leading the government’s Covid vaccine taskforce, has received almost $50 million of state funding.British Patient Capital and Mubadala, the Abu Dhabi sovereign wealth fund, are co-investing

This content was originally published here.